Cassava Sciences Inc (NASDAQ:SAVA)

45.53
Delayed Data
As of Oct 22
 -0.85 / -1.83%
Today’s Change
6.70
Today|||52-Week Range
146.16
+567.60%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$1.8B

Company Description

Cassava Sciences, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer's disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier and Barry M. Sherman in May 1998 and is headquartered in Austin, TX.

Contact Information

Cassava Sciences, Inc.
7801 North Capital of Texas Highway
Austin Texas 78731
P:(512) 501-2444
Investor Relations:
(512) 501-2450

Employees

Shareholders

Individual stakeholders5.65%
Mutual fund holders14.01%
Other institutional13.53%

Top Executives

Remi BarbierChairman, President & Chief Executive Officer
Nadav FriedmannDirector, Chief Operating & Medical Officer
Eric J. SchoenChief Financial Officer
James W. KupiecChief Clinical Development Officer
Michael ZamlootSenior Vice President-Technical Operations